CollPlant Biotechnologies Ltd.
CLGN
$0.42
$0.013.38%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 515.00K | 650.00K | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 515.00K | 650.00K | |
| Cost of Revenue | -- | -- | 1.63M | 2.13M | |
| Gross Profit | -- | -- | -1.11M | -1.48M | |
| SG&A Expenses | -- | -- | 5.63M | 5.78M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 17.77M | 19.00M | |
| Operating Income | -- | -- | -17.25M | -18.35M | |
| Income Before Tax | -- | -- | -16.61M | -17.42M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -16.61 | -17.42 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -16.61M | -17.42M | |
| EBIT | -- | -- | -17.25M | -18.35M | |
| EBITDA | -- | -- | -16.21M | -17.27M | |
| EPS Basic | -- | -- | -1.45 | -1.52 | |
| Normalized Basic EPS | -- | -- | -0.44 | -0.49 | |
| EPS Diluted | -- | -- | -1.45 | -1.52 | |
| Normalized Diluted EPS | -- | -- | -0.44 | -0.49 | |
| Average Basic Shares Outstanding | -- | -- | 45.82M | 45.82M | |
| Average Diluted Shares Outstanding | -- | -- | 45.82M | 45.82M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |